Stephen B. Howell

Stephen B. Howell was the founder of Targa Pharmaceuticals (founded in 2003) and DepoTech Corp.
(founded in 1989) where he holds the titles of Medical Director and Chairman respectively.
Dr. Howell is also the founder of Beacon Laboratories, Inc. Dr. Howell's current job(s) include being a Director at Splash Pharmaceuticals, Inc., Director-Cancer Pharmacology Program at The UC San Diego Cancer Center Foundation (since 2006), a Professor at the University of California San Diego (since 2011), and a Member of the American Society of Clinical Oncology, Inc. and the American Association for Cancer Research.
Dr. Howell's former job(s) include being the Chief Executive Officer & Medical Consultant at Targa Therapeutics Corp.
(2002-2009), a Director at Matrix Pharmaceutical, Inc. (2000-2002), an Independent Director at Abeona Therapeutics, Inc. (2011-2020), a Director at Repros Therapeutics, Inc., an Associate Director-Moores Cancer Clinical Research at UC San Diego Health System, and the Chief Medical Officer at Aptose Biosciences, Inc. (2014-2020).
Dr. Howell's education includes an undergraduate degree from The University of Chicago and a doctorate from Harvard Medical School.